期刊文献+

单纯高血压病及高血压病合并冠心病患者血清醛固酮及血管紧张素Ⅰ、Ⅱ水平的研究 被引量:9

Investigation of plasma level of aldosterone,angiotensin Ⅰ and angiotensin Ⅱ in patients with hypertension and hypertension combined with coronary heart disease
下载PDF
导出
摘要 目的探讨单纯高血压病及高血压病合并冠心病患者血清醛固酮(ALD)、血管紧张素Ⅰ(AngⅠ)及血管紧张素Ⅱ(AngⅡ)水平,了解其与高血压病分级及冠状动脉受累程度的关系。方法纳入108例患者,其中单纯高血压病组81例,分为高血压病2级亚组(n=28)及高血压病3级亚组(n=53);高血压病合并冠心病组27例,分为1支病变亚组(n=9)、2支病变亚组(n=10)及3支病变亚组(n=8),用放射免疫法测定各组血清ALD、AngⅠ及AngⅡ含量。结果高血压病合并冠心病组血清ALD高于单纯高血压病组,差异有统计学意义(P<0.05),而AngⅠ及AngⅡ水平差异无统计学意义(P>0.05)。单纯高血压病组中,高血压病3级亚组血清ALD、AngⅠ及AngⅡ水平均明显高于高血压病2级亚组,差异有统计学意义(P<0.05,P<0.01)。高血压病合并冠心病组中,3支病变亚组血清ALD、AngⅡ水平明显高于1支病变亚组及2支病变亚组,差异有统计学意义(P<0.05)。2组中应用ACEI/ARB与未应用ACEI/ARB患者比较,上述3项指标差异均无统计学意义(P>0.05)。结论同时测量ALD、AngⅠ及AngⅡ水平有助于评估高血压病的分级及冠状动脉受累的严重程度。 Objective To observe the level of plasma aldosterone(ALD),angiotensinⅠ(AngⅠ) and angiotensinⅡ(AngⅡ) detected in patients with hypertension and hypertension combined with coronary heart disease(CHD),also investigate the relationship between them.Methods 108 patients with essential hypertension were enrolled in the study.The plasma level of ALD,AngⅠand AngⅡwere detected in 81 patients with single hypertension and in 27 patients combined with coronary heart disease by RIA.Depending on the level of blood pressure,81 single hypertension patients were divided into 2 sub-groups: gradeⅡ(n =28) and gradeⅢ(n =53).27 patients who underwent coronary angiography and diagnosed of CHD were divided into 3 sub-groups:single vessel group(n =9),2 vessels group(n =10) and 3 vessels and /or left main artery lesions group(n =8).Results The plasma level of ALD in patients combined with coronary heart disease were significant higher than those of single hypertension patients(P0.05 ),while there were no statistical differences between the level of AngⅠand AngⅡ.The plasma level of ALD,AngⅠand AngⅡin patients with gradeⅢhypertension were significantly higher than those of gradeⅡhypertension in essential hypertension group(P0.05,P0.01 ).In the hypertension combined CHD group,the plasma level of ALD and AngⅡin patients with 3 vessels and/or left main artery lesions were significantly higher than those with single vessel and 2 vessels disease(P0.05).There were no statistical differences of the 3 index in both groups whether the patients take the ACEI/ARB or not(P0.05).Conclusion Dynamic observation the level of ALD,AngⅠand AngⅡmay be very useful in assessment of severity and prognosis of patients with hypertension and coronary heart disease.
出处 《疑难病杂志》 CAS 2011年第7期484-486,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 高血压病 冠心病 醛固酮 血管紧张素Ⅰ 血管紧张素Ⅱ Hypertension Coronary heart disease Aldosterone AngiotensinⅠ AngiotensinⅡ
  • 相关文献

参考文献17

  • 1Keidar S,Kaplan M,Pavlotzky E,et al.Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development:a possible role for angiotensin 2 converting enzyme and the receptors for angiotensin Ⅱand aldosterone[J].Circulation,2004,109 (18):2213-2220.
  • 2Farquharson CA,StruthersAD.Aldosterone induces acute endothelial dysfunction in vivo in humans:evidence for an aldosterone induced vasculopathy[J].Clin Sci,2002,103(4):425-431.
  • 3Ouvrard-Pascaud A,Sainte-Marie Y,Benitah JP,et al.Conditional mineralocorticoid receptor expression in the heart leads to life threatening arrhythmias[J].Circulation,2005,111(23):3025-3033.
  • 4Gaddam KK,Pimenta E,Husian S,et al.Aldosterone and cardiovascular disease[J].Curr Probl Cardiol,2009,34(2):51-84.
  • 5Genest J,Lemieux G,Davignon A,et al.Human arterial hypertension:a state of mild chronic hyperaldosteronism[J]Science,1956,123(3195):503-505.
  • 6Vasan RS,Evans JC,Larson MG.Serum aldosterone and the incidence of hypertension in nonhypertensive persons[J].N Engl J Med,2004,351(1):33-41.
  • 7Newton-Cheh C,Guo CY,Gona P,et al.Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample[J].Hypertension 2007,49(4):846-856.
  • 8Grim CE,Cowley Jr AW,Hamet P,et al.Hypertension and hypertension:ethnic differences[J].Hypertension,2005,45(4pt2):766-772.
  • 9Duprez DA,Bauwens FR,Debuyzere ML,et al.Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension[J].Am J Cardiol,1993,71(3):17A-20A.
  • 10Ward MR,Kanellakis P,Ramsey D,et al.Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries[J].Circulation,2001,104(4):467-472.

二级参考文献11

  • 1Thompson MM,Squire IB.Matrix metalloproteinase-9 expression after myoeardial infaretion:physiological or pathological[J].Cardiovasc Res,2002:54(3):495-498.
  • 2Romanie AM,Harrison M,Bao WK,et al.Myocardial protection from ischemia/reperfusion in jury by targeted deletion of matrix metalloproteinase-9[J].Cardiovasc Res,2002,54(3):549-558.
  • 3Kai H,Ikeda H,Yasukawa H,et al.Peripheral blood levels of matrixmetalloproteinase-2 and -9 are elevated in patients with acute coronary syndromes[J].J Am Coll Cardiol,1998,32(92):368-372.
  • 4Mann DL,Bristow MR.Mechanisms and models in heart failure:the biomechanical model and beyond[J].Circulation,2005,111(21):2837-2849.
  • 5Pfeffer MA,Lamas GA,Vaughan DE,et al.Effect of captoppril on progressive ventricular dilatation after anterior myocardial infarction[J].N Engl J Med,1998,319(2):80-86.
  • 6Bhakta S,Dunlap ME.Angiotensin-receptor blockers in heart failure:evidence from the CHARM trial[J].Cleve Clin J Med,2004,71(8):665-673.
  • 7Henry K,Peter C,Csaba F,et al.Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure:results from Val-HeFT[J].Eur J Heart Fail,2004,6(7):937-945.
  • 8Zannad F,Alla F,Dousset B,et al.Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure:insights from the randomized aldactone evaluation study (RALES)[J].Circulation,2000,102(11):2700-2706.
  • 9Pitt B,Ruilope L,Bakris G.et al.Risk/benefit analysis of hyperkalemia in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)[J].Eur J Heart Fail Suppl,2004,3(1):116.
  • 10Pitt B,White H,Nicolau J,et al.Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure[J].J Am Coll Cardiol,2005,46(10):425-431.

共引文献2

同被引文献63

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部